
Sign up to save your podcasts
Or
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill’s conclusions.
5
1717 ratings
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill’s conclusions.
501 Listeners
124 Listeners
3,339 Listeners
1,141 Listeners
115 Listeners
122 Listeners
190 Listeners
514 Listeners
68 Listeners
249 Listeners
4 Listeners
181 Listeners
1 Listeners
0 Listeners
6 Listeners